Top Clinical Trials companies in Switzerland by Net Cash Used Provided By Financing Activities
Switzerland
# |
Name |
Net Cash Used Provided By Financing Activities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 479.70 M
|
Dec. 31, 2023 | USD 45.99 | -2.40% |
|
Switzerland |
|
| 2 |
USD 154.02 M
|
Dec. 31, 2023 | USD 22.91 | 2.51% |
|
Switzerland |
|
| 3 |
USD 73.88 M
|
Dec. 31, 2023 | USD 1.68 | -2.33% |
|
Switzerland |
|
| 4 |
USD 51.37 M
|
Dec. 31, 2023 | USD 2.75 | 1.85% |
|
Switzerland |
|
| 5 |
USD 1.63 M
|
Dec. 31, 2023 | USD 2.49 | 25.76% |
|
Switzerland |
|
| 6 |
USD -203.10 K
|
Dec. 31, 2023 | USD 24.30 | -3.46% |
|
Switzerland |
|
| 7 |
USD -1.39 M
|
Dec. 31, 2023 | USD 5.05 | -4.17% |
|
Switzerland |
|
| 8 |
USD -68.06 M
|
Dec. 31, 2023 | USD 43.76 | -1.99% |
|
Switzerland |
|
| 9 |
USD -112.54 M
|
Dec. 31, 2023 | USD 1.12 K | -0.26% |
|
Switzerland |
Frequently Asked Questions
-
Which Clinical Trials company in Switzerland has the highest Net Cash Used Provided By Financing Activities ?
The Clinical Trials company in Switzerland with the highest Net Cash Used Provided By Financing Activities is MoonLake Immunotherapeutics (NasdaqCM: MLTX) at USD 479.70 M.
-
Which Clinical Trials company in Switzerland has the lowest Net Cash Used Provided By Financing Activities ?
The Clinical Trials company in Switzerland with the lowest Net Cash Used Provided By Financing Activities is Siegfried Holding AG (Swiss Stock Exchange: SFZN.SW) at USD -112.54 M.
-
What are the top 10 Clinical Trials companies in Switzerland by Net Cash Used Provided By Financing Activities ?
The top 10 Clinical Trials companies in Switzerland by Net Cash Used Provided By Financing Activities are MoonLake Immunotherapeutics, Oculis Holding AG, ADC Therapeutics SA, AC Immune SA, NLS Pharmaceutics AG, Kuros Biosciences AG, Molecular Partners AG, Basilea Pharmaceutica AG and Siegfried Holding AG.
-
What are the bottom 10 Clinical Trials companies in Switzerland by Net Cash Used Provided By Financing Activities ?
The bottom 10 Clinical Trials companies in Switzerland by Net Cash Used Provided By Financing Activities are Siegfried Holding AG, Basilea Pharmaceutica AG, Molecular Partners AG, Kuros Biosciences AG, NLS Pharmaceutics AG, AC Immune SA, ADC Therapeutics SA, Oculis Holding AG and MoonLake Immunotherapeutics.
